Critical Monoclonal Antibodies & Reagents for Neurodegenerative Biomarker Assays
Engineered for sub-picogram analytical sensitivity across CLIA, Simoa, and point-of-care platforms. As a dedicated supplier of clinical-grade IVD raw materials, we deliver validated matched antibody pairs and recombinant calibrators with multi-gram batch consistency and strict lot-to-lot reproducibility.
Tailored IVD Reagent Solutions & OEM Manufacturing
Eliminating international biological import barriers. Accelerate your assay pipeline with customized conjugations, custom buffer formulations, and sequence-based recombinant synthesis under mutual NDA.
Ready-to-Use Conjugation & Labeling
Bypass in-house coupling losses and batch inconsistencies. Receive assay-ready antibody conjugates tailored specifically for your target detection technology.
- ✓ Acridinium Ester (AE) labeled for CLIA
- ✓ High-affinity Biotinylation (custom spacer arms)
- ✓ HRP, ALP, & fluorescent fluorophores (FITC)
- ✓ Functionalized magnetic microparticle coating
Custom Formulation & Bulk Filling
Engineered for clinical kit manufacturing lines. We accommodate specific buffer matrices, zero-preservative requests, and gram-scale sterile batch packaging.
- ✓ Preservative-free (Sodium Azide-free) options
- ✓ Tailored buffer exchange (Trehalose, Glycerol, PBS)
- ✓ High-concentration concentrates (up to 10 mg/mL)
- ✓ OEM private labeling & customized fill volumes
Sequence-to-Protein Synthesis
Zero physical sample shipping hurdles. Provide your FASTA sequence electronically for high-fidelity recombinant antigen and calibrator production.
- ✓ Mammalian (HEK293 / CHO) & E. coli expression
- ✓ Phosphorylated & conformational mutant targets
- ✓ Recombinant authentic calibrators & controls
- ✓ Stringent purity assessment (>95% SDS-PAGE/SEC)
Technology Platforms & Quality Advantages
Eliminating batch variance in clinical diagnostic manufacturing. Engineered with strict biophysical release criteria to guarantee robust analytical reproducibility across diverse immunoassay architectures.
Ultra-Low Lot-to-Lot Variation
Scale-up protocols eliminate inter-batch drift. We establish single-batch bioreactor fermentation up to multi-gram scales, preventing frequent platform re-calibration for diagnostic kit developers.
- ■ Strict lot-to-lot CV < 5% across analytical calibration curves
- ■ Cryopreserved Master & Working Cell Banks (MCB/WCB)
- ■ Gram-scale single harvest lots with identical binding kinetics
Multi-Platform Analytical Validation
Not just RUO binding tests. Raw materials are rigorously screened and paired directly on magnetic microparticle CLIA, ELISA, and digital single-molecule (Simoa) platforms against real human serum and plasma.
- ■ Spike-and-recovery rates maintained within 90% – 110%
- ■ Minimal interference from endogenous bilirubin, lipids, & HAMA
- ■ Benchmarked against international reference standards and PET status
Stringent Biophysical QC Release
Every delivered batch is characterized through an orthogonal analytical battery to confirm monomer purity, binding kinetics, and prolonged shelf-life stability before release.
- ■ Monomer purity > 98% via analytical Size-Exclusion HPLC (SEC-HPLC)
- ■ Real-time binding kinetics ($K_D$, $k_{on}$, $k_{off}$) by BLI / SPR analysis
- ■ Accelerated thermal stability validation (14 days at 37°C without loss)
Ready to Validate or Scale Your Diagnostic Assay?
Request evaluation sample packs, review detailed analytical validation reports, or discuss bulk supply agreements directly with our technical support team.